Watson Oncology

IBM’s Watson Falls Short in Cancer Care

Watson is perhaps one of the best known examples of commercially available artificial intelligence. In February 2013, IBM announced that Watson’s first application would be for managing aspects of lung cancer treatment at Memorial Sloan Kettering Cancer Center in New York City. IBM claimed that at one point 90% of nurses in the field followed Watson’s guidance. Impressed? Now comes an investigative report from STAT finding that three years after IBM began selling Watson to cancer hospitals around the world, “the supercomputer isn’t living up to the lofty expectations IBM created for it. It is still struggling with the basic step of learning about different forms of cancer.” The article concludes: “The interviews suggest that IBM, in its rush to bolster flagging revenue, unleashed a product without fully assessing the challenges of deploying it in hospitals globally.” —TV

Photo: ibmphoto24